ICP-OES Spectrometer Industry Size, Share, Key Players, Growth Trend, and Forecast Till 2030

 


The global ICP-OES Spectrometer Industry was valued at USD 521.4 million in 2018 at a CAGR of 7.2% during the forecast period of 2019 to 2025.

ICP-OES Spectrometer is an analytical instrument that is used for the detection of chemical elements. It uses the technique of inductively coupled plasma optical emission spectroscopy (ICP-OES) for carrying out its analysis procedure. Certain factors that propel the growth of the ICP-OES Spectrometer Industry include increasing R&D expenditure for the development of better analytical systems and growing technological advancements.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8120

However, the high cost of instruments and requirement of large capital investment for setting up instrument manufacturing plants is hindering the growth of the global ICP-OES Spectrometer Industry in the forecast period.

Currently, the global ICP-OES Spectrometer Industry is dominated by several players. The major players in this market are involved in strategic acquisitions and product launches to expand their product portfolios. For instance, in March 2016, GBC Scientific Equipment launched the OptiMass 9600, which uses the ICP-OES spectrometer technology.

Segmental Analysis

The global ICP-OES Spectrometer Industry has been segmented based on spectrometer type, application, end user, and region.

The market, based on spectrometer type, has been segmented into sequential and simultaneous. The sequential spectrometer market is expected to hold a major share in the market owing to its wider availability in the market. The sequential spectrometer market is anticipated to be the fastest-growing due to its rising adoption rate in the industry.

The market, by application, has been divided into nanotechnology, drug discovery, environmental testing, food & agriculture, and others. The drug discovery segment is expected to hold a major share owing to its large number of applications in the market. The environmental testing segment is expected to be the fastest-growing due to the rising number of research activities for using ICP-OES spectrometer for environmental testing purpose.

The market, by end user, has been classified as pharmaceutical & biotechnology companies, research & academic institutes, and others. The pharmaceutical and biotechnology companies’ segment is anticipated to hold a major share in the market due to the increasing number of applications of ICP-OES spectrometer in the pharmaceutical industry. The research & academic institutes segment is expected to be the fastest-growing market due to the rising number of research activities.

Key Players

Some of the key players in the global ICP-OES Spectrometer Industry are PerkinElmer Inc. (US), Shimadzu Corporation (Japan), GBC Scientific Equipment (Australia), Thermo Fisher Scientific (US), Agilent Technologies, Inc. (US), SPECTRO Analytical Instruments GmbH (Germany), Teledyne Leeman Labs (US), Analytik Jena AG (Germany), Horiba (Japan), Skyray Instrument Inc. (US), Beijing Huake Tiancheng Technology Co., Ltd (China), FPI (China), Hitachi High-Technologies Corporation (Japan), Merck KGaA (Germany), and others.

Regional Analysis

The global ICP-OES Spectrometer Industry, by region, is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The ICP-OES Spectrometer Industry in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada. The European ICP-OES Spectrometer Industry has been sub-divided into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The ICP-OES Spectrometer Industry in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The ICP-OES Spectrometer Industry in the Middle East & Africa has been divided into the Middle East and Africa.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/icp-oes-spectrometer-market-8120

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Opioid Withdrawal Treatment Market Growth, Size Analysis, DROT, PEST, Porter’s, Region & Country Forecast Till 2030

Image
The global  opioid withdrawal treatment growth market held a market value of USD 1.8 billion in 2018 and is projected to grow at a CAGR of 10.1% over the forecast period. Opioids are drugs such as heroin, opium, morphine, codeine, and methadone that are used in cases of severe, postsurgical, or chronic pain. In some cases, usage of opioids causes addiction, and Opioid withdrawal syndrome is a life-threatening condition resulting from opioid dependence. These drugs can also cause severe health problems and sometimes even result in overdose and loss of life. Hence this opioid dependence requires treatment, which is known as opioids withdrawal treatment. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8123 Segmentation The global opioid withdrawal treatment market has been segmented into drug type and distribution channel. By drug type, the market has been segmented into the nonsteroidal anti-inflammatory drugs, anti-nausea medications, a...
Read more

Preclinical Imaging Market Trends, Size, Key Factors, Major Players, Growth Strategies, Forecast Till 2027

Image
Preclinical Imaging Market Trends , Revenue Forecast, Competitive Landscape, Growth Factors, and Research Report: by Product (Optical Imaging, Nuclear Imaging, Micro-MRI, Micro-Ultrasound, Micro-CT, Photoacoustic Imaging System), by Reagent (Optical, Nuclear, CT Contrast Agents, MRI Contrast Agents) The global preclinical imaging anticipated to have held a market value of USD 2.01 billion in the year 2017 and is expected to grow at a CAGR of 6.3% during the forecast period. Preclinical imaging solutions are used during the preclinical research for visualization of living animals. It is playing important role during drug development process. It is evaluating the effectiveness and safety of new treatments and describing drug distribution patterns before clinical use. preclinical imaging solutions has broad application field such as, neurology; cardiology; inflammation; infectious diseases; cancer research; functional and anatomical neuroimaging, orthopedics; and cardiac imaging. Requ...
Read more